| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |